(AKE) Arkema - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0010313833

AKE EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of AKE over the last 5 years for every Quarter.

AKE Revenue

This chart shows the Revenue of AKE over the last 5 years for every Quarter.

AKE: Adhesives, Polymers, Coatings, Additives, Chemicals

Arkema SA is a global specialty chemicals company operating in three distinct segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The company provides a wide range of innovative materials and solutions that cater to various industries, including construction, automotive, electronics, and energy. With a presence in over 50 countries, Arkema has established itself as a leading player in the global chemicals market.

The Adhesive Solutions segment is a key contributor to Arkemas revenue, offering a diverse portfolio of products that include sealants, adhesives, and waterproofing systems. The segments focus on innovation and customer-centricity has enabled Arkema to maintain a strong market position. Additionally, the companys performance polymers and additives business provides a range of high-performance materials used in various industrial applications.

The Advanced Materials and Coating Solutions segment is another significant revenue driver for Arkema, offering a range of coating solutions, additives, and specialties that cater to various industries, including decorative paints, industrial coatings, and adhesives. The segments focus on innovation and sustainability has enabled Arkema to stay ahead of the competition.

From a technical analysis perspective, Arkemas stock price has been trending downwards, with the SMA20 and SMA50 indicators suggesting a bearish trend. The stock is currently trading below its 200-day moving average, indicating a potential long-term downtrend. However, the ATR indicator suggests that the stocks volatility is relatively low, which could be a positive sign for investors.

Using the available and , we can forecast that Arkemas stock price may continue to face downward pressure in the short term, driven by the bearish trend and the companys relatively low ROE. However, the stocks P/E forward ratio of 9.13 suggests that the company is undervalued, and the dividend yield could be attractive to income investors. A potential buying opportunity could arise if the stock price were to decline further, towards its 52-week low of 56.65. Conversely, a break above the SMA200 indicator at 71.55 could signal a potential long-term uptrend.

Based on the available data, our forecast is that Arkemas stock price will trade between 55 and 65 in the next 6 months, with a potential bias towards the lower end of this range. However, investors should closely monitor the companys fundamental performance and technical indicators for any signs of a turnaround.

Additional Sources for AKE Stock

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

AKE Stock Overview

Market Cap in USD 5,261m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Diversified Chemicals
IPO / Inception

AKE Stock Ratings

Growth Rating -31.8
Fundamental 3.39
Dividend Rating 75.4
Rel. Strength -23.2
Analysts -
Fair Price Momentum 55.96 EUR
Fair Price DCF 58.17 EUR

AKE Dividends

Dividend Yield 12m 5.34%
Yield on Cost 5y 5.08%
Annual Growth 5y 9.73%
Payout Consistency 97.2%
Payout Ratio 91.4%

AKE Growth Ratios

Growth Correlation 3m -14.8%
Growth Correlation 12m -74.7%
Growth Correlation 5y -31%
CAGR 5y -2.78%
CAGR/Max DD 5y -0.05
Sharpe Ratio 12m -0.62
Alpha -29.65
Beta 0.589
Volatility 27.80%
Current Volume 203.6k
Average Volume 20d 195.5k
What is the price of AKE shares?
As of June 26, 2025, the stock is trading at EUR 61.40 with a total of 203,551 shares traded.
Over the past week, the price has changed by +2.93%, over one month by -3.91%, over three months by -14.27% and over the past year by -23.33%.
Is Arkema a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Arkema is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 3.39 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AKE is around 55.96 EUR . This means that AKE is currently overvalued and has a potential downside of -8.86%.
Is AKE a buy, sell or hold?
Arkema has no consensus analysts rating.
What are the forecasts for AKE share price target?
According to our own proprietary Forecast Model, AKE Arkema will be worth about 62.8 in June 2026. The stock is currently trading at 61.40. This means that the stock has a potential upside of +2.25%.
Issuer Target Up/Down from current
Wallstreet Target Price 86.4 40.7%
Analysts Target Price - -
ValueRay Target Price 62.8 2.2%